These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4773984)

  • 21. Levodopa and amantadine in the treatment of Parkinsonism.
    Critchley E
    Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychoactive properties of amantadine.
    Wilcox J
    J Psychoactive Drugs; 1985; 17(1):51-3. PubMed ID: 3981306
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of parkinsonism with viregyt (amantadine)].
    Pryszmont M; Jankowicz E; Eljasz L; Slizewski M; Wiśniewska Z
    Wiad Lek; 1974 Aug; 27(15):1371-5. PubMed ID: 4418066
    [No Abstract]   [Full Text] [Related]  

  • 24. Corneal endothelial dysfunction associated with amantadine toxicity.
    Chang KC; Kim MK; Wee WR; Lee JH
    Cornea; 2008 Dec; 27(10):1182-5. PubMed ID: 19034138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
    Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC
    Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599
    [No Abstract]   [Full Text] [Related]  

  • 26. Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease.
    Gondim Fde A; Costa HA; Taunay TC; de Oliveira GR; Ferreira JM; Rola FH
    Mov Disord; 2010 Jul; 25(10):1505-6. PubMed ID: 20629118
    [No Abstract]   [Full Text] [Related]  

  • 27. [Long-term therapy of parkinsonism using amantadine salts].
    Damielczyk W; Struppler A; Velho-Groneberg P; Clemens R; Diehl LW
    Med Welt; 1976 Apr; 27(14):669-75. PubMed ID: 1263820
    [No Abstract]   [Full Text] [Related]  

  • 28. [Amantadine for parkinsonism].
    Flatberg P
    Tidsskr Nor Laegeforen; 1970 May; 90(10):1101-2. PubMed ID: 5450047
    [No Abstract]   [Full Text] [Related]  

  • 29. [Amantadine therapy in parkinsonism].
    Pakkenberg H
    Ugeskr Laeger; 1973 Jan; 135(3):135-6. PubMed ID: 4685048
    [No Abstract]   [Full Text] [Related]  

  • 30. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 31. [Principles for amantadine therapy in parkinsonism].
    Gilland O
    Lakartidningen; 1972 Nov; 69(46):5343-5. PubMed ID: 4650743
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of amantadine in parkinsonism: clinical and neurophysiological findings].
    Fünfgeld EW
    Dtsch Med Wochenschr; 1970 Sep; 95(36):1834-6. PubMed ID: 5453004
    [No Abstract]   [Full Text] [Related]  

  • 33. [Amantadine therapy in Parkinsonism].
    Forssman B; Kihlstrand S; Larsson LE
    Lakartidningen; 1972 Mar; 69():55-9. PubMed ID: 4577428
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma amantadine concentrations in patients with Parkinson's disease.
    Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M
    Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coloured Lilliputian hallucinations with amantadine.
    Harper RW; Knothe BU
    Med J Aust; 1973 Mar; 1(9):444-5. PubMed ID: 4708929
    [No Abstract]   [Full Text] [Related]  

  • 36. [Combined therapy of parkinsonism using amantadine].
    Umbach W; Oppel F
    Munch Med Wochenschr; 1973 Apr; 115(14):604-7. PubMed ID: 4740225
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
    Hacohen H; Gurtner B
    Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
    [No Abstract]   [Full Text] [Related]  

  • 38. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract]   [Full Text] [Related]  

  • 39. L-dopa and amantadine in the therapy of parkinsonism.
    Weeth JB; Shealy CN; Mercier DA
    Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055
    [No Abstract]   [Full Text] [Related]  

  • 40. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial.
    Appleton DB; Eadie MJ; Sutherland JM
    Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.